Document is current
Any future updates will be listed below
-
Authors
Delignette, M. C.
Riff, A.
Antonini, T.
Soustre, T.
Bodinier, M.
Peronnet, E.
Venet, F.
Gossez, M.
Pantel, S.
Mabrut, J. Y.
Muller, X.
Mohkam, K.
Villeret, F.
Erard, D.
Dumortier, J.
Zoulim, F.
Heyer, L.
Guichon, C.
Blet, A.
Aubrun, F.
Monneret, G.
Lebossé, F.
- License Information
-
More Information
Article History
Received: 14 November 2024
Accepted: 30 January 2025
First Online: 18 February 2025
Declarations
:
: The study was approved by the Comité de Protection des Personnes Ile de France XI (approval number 19039-40433). Written informed consent was obtained from all participants prior to enrollment. The study complied with the Declaration of Helsinski. The study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
: Not applicable.
: MB and EP are employees of BioMérieux SA, an in vitro diagnostic company. MCD, MB, EP, FV, MG and GM work in a joint research unit, co-funded by the Hospices Civils de Lyon and bioMérieux.
